Disclosure Policy of the Astellas Group for Information on Conduct and Results of Clinical...
The Astellas Group (*1) (hereinafter collectively “Astellas”) recognises that making clinical trial information and results...
Bausch + Lomb and Nicox Announce FDA Acceptance of New Drug Application for Novel...
Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary, Bausch + Lomb, and Nicox S.A. announced that...
CTI BioPharma To Submit NDA For Pacritinib In Q4 Based Primarily On Data From...
CTI BioPharma Corp. announced its plan to submit a new drug application (NDA) to the...
Pivotal Phase 3 Studies of Bezlotoxumab, Merck’s Investigational Antitoxin to Prevent Clostridium Difficile Infection...
Merck known as MSD outside the United States and Canada, today announced that the two...
Enox Biopharma, LTD. Announces First Enrollments of A Phase 1a/lb Clinical Trial
Enox Biopharma, Ltd., a leader in nitric oxide delivery technology for the prevention of hospital...
Otsuka and GW Pharmaceutical’s multiple sclerosis drug Sativex has failed to meet the primary...
Sativex (nabiximols) is derived from cannabis and usually used to treat the symptoms of multiple...
TxCell announces start of phase IIb clinical trial with Ovasave(R) for refractory Crohn’s disease
TxCell undertaking one of largest ever controlled studies for a personalized T cell immunotherapy...
Sanofi and Regeneron report positive Phase IIb trial results of dupilumab in asthma patients
Sanofi and Regeneron Pharmaceuticals have reported positive results from the interim analysis of a dose-ranging...
Sarepta doses first patient in eteplirsen trial to treat duchenne muscular dystrophy
US-based Sarepta Therapeutics has started dosing patients in a clinical trial of its lead exon-skipping...
TxCell achieves positive results for Col-Treg in a model of autoimmune uveitis
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its...
